SGLTR Tablet 10's

• SGLTR Tablet contains Remogliflozin Etabonate 100mg used to treat type 2 diabetes mellitus
• It helps to control high blood sugar levels and also prevent heart diseases
• Chemical Class: O-glycosyl derivatives
• Addictive Drug: No
• Therapeutic Class: Anti Diabetic
• Action Class: SGLT2 inhibitors
• Schedule “H” drug Warning: Not to be sold without the prescription of a registered medical practitioner
• Store at a normal temperature below 30°C
• Keep out of the reach of children and pets

Treatment of Type 2 diabetes Mellitus

• Avoid consuming alcohol or smoking while taking SGLTR Tablet
• Avoid driving or if you want to do any work with concentration while taking this tablet
• Avoid intake os this Tablet already having cardiovascular diseases
• Inform your healthcare provider of all medications you are taking, including prescription and over-the-counter drugs, vitamins, and herbal supplements

Inform your doctor if you take any of the following medicines before using SGLTR Tablet
 

• Diuretics
• Blood pressure medications
• Insulin
• Non-steroidal anti-inflammatory drugs (NSAIDs)

SGLTR Tablet is not safe to intake without a doctor's advice during pregnancy because the active ingredient in these medications can cross the placenta and may affect the development of the fetus. Breastfeeding mothers also must consult their doctors for the usage of this medicine

• SGLT2 inhibitors increase the amount of glucose and fluid eliminated in the urine, so it's important to drink plenty of water to prevent dehydration
• A healthy diet and regular physical activity are important components of managing type 2 diabetes while intaking SGLTR Tablet
• SGLTR Tablet can cause low blood sugar levels (hypoglycemia), particularly in combination with other diabetes medications, always carry glucose gel or candy, on hand
• SGLT2 inhibitors include genital infections, urinary tract infections, and low blood pressure (hypotension). If you experience any side effects, it's important to inform your doctor
• Exactly follow your doctor's instruction to intake this medicine (dose and duration)
• Do not stop the intake of this medicine without your doctor's advice

• Urinary tract infections
• Yeast infections
• Dehydration
• Low blood pressure (hypotension)
• Constipation
• Hypoglycemia (low blood glucose level)
• Increased urination
• Nausea
• Diarrhoea
• Fever
• Cough
• Dyslipidemia
  
  
  If you experience any side effects while using SGLTR Tablet, speak with your doctor

• Swallow the tablet whole with a glass of water, do not crush or break or chew it
• Do not overdose oo this medication, if you forget to intake the medicine on time or skip it and take as per regular schedule

SGLTR Tablet contains Remogliflozin Etabonate is a sodium-glucose cotransporter 2 (SGLT2) inhibitor medication used to treat type 2 diabetes


It works by blocking the reabsorption of glucose in the kidneys and promoting the excretion of glucose in the urine


In patients with type 2 diabetes, the body becomes resistant to insulin or the pancreas doesn't produce enough insulin, leading to an accumulation of glucose in the blood. SGLT2 inhibitors like Remogliflozin Etabonate help to reduce the amount of glucose in the blood by preventing its reabsorption in the kidneys and promoting its excretion in the urine. This results in lower blood sugar levels and improved glycemic control


It's important to note that Remogliflozin Etabonate should not be used as a substitute for diet and exercise to manage type 2 diabetes. It should be used in conjunction with a healthy diet and physical activity to achieve the best results

Q: Does SGLTR tablet cause weight loss?
Yes, SGLT2 inhibitors have been associated with weight loss as a side effect. This occurs because the body is eliminating glucose and calories in the urine, leading to a reduction in overall calorie intake

Q: Can SGLTR tablet lower blood pressure?
SGLTR tablet can cause lower blood pressure, consult your doctor

Q: Can SGLT2 tablet cause genital infections?
The use of SGLT2 inhibitors has been associated with an increased risk of genital infections, such as yeast infections and urinary tract infections
 

Q: Can Remogliflozin Etabonate be used in combination with other diabetes medications?
Yes, Remogliflozin Etabonate can be used in combination with other medications, to manage blood sugar levels in people with type 2 diabetes

• SGLTR Tablet has been associated with an increased risk of genital infections, such as yeast infections and urinary tract infections
• It may not be safe for people with severe kidney disease, consult your doctor
• Patients with liver disease may be at increased risk for liver-related side effects when taking SGLTR Tablet
• This tablet may increase the risk of urinary tract infections, consult your doctor
• SGLT2 inhibitors can cause a buildup of ketones in the blood, which can be a sign of diabetic ketoacidosis. If you experience symptoms such as nausea, vomiting, abdominal pain, or difficulty breathing, it is important to check for ketones and inform your doctor immediately